cefminox has been researched along with Experimental Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawaharajo, K; Murata, S; Niizeki, M; Sekizawa, Y; Shitoh, K | 1 |
1 other study(ies) available for cefminox and Experimental Neoplasms
| Article | Year |
|---|---|
Therapeutic efficacy of a new cephamycin, MT-141, in compromised mice.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Bactericidal Activity; Cephamycins; Complement Activation; Guinea Pigs; Immune Tolerance; Male; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Neutropenia | 1984 |